Cofactor Genomics Publishes OncoPrism — NSCLC Clinical Validation, Advancing Lung Cancer Immunotherapy Diagnostics Beyond PD — L1
For best results when printing this announcement, please click on link below: Cofactor Genomics Publishes OncoPrism-NSCLC Clinical Validation, Advancing Lung Cancer Immunotherapy Diagnostics Beyond PD-L1 The study showed OncoPrism-NSCLC significantly predicted overall response and identified the subset of patients with